110 related articles for article (PubMed ID: 24512866)
41. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation.
Senore C; Armaroli P; Silvani M; Andreoni B; Bisanti L; Marai L; Castiglione G; Grazzini G; Taddei S; Gasperoni S; Giuliani O; Malfitana G; Marutti A; Genta G; Segnan N
Am J Gastroenterol; 2010 Jan; 105(1):188-98. PubMed ID: 19826409
[TBL] [Abstract][Full Text] [Related]
42. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
43. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial.
Hoffman RM; Steel S; Yee EF; Massie L; Schrader RM; Murata GH
Prev Med; 2010; 50(5-6):297-9. PubMed ID: 20307568
[TBL] [Abstract][Full Text] [Related]
44. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
[TBL] [Abstract][Full Text] [Related]
45. Tailored navigation in colorectal cancer screening.
Myers RE; Hyslop T; Sifri R; Bittner-Fagan H; Katurakes NC; Cocroft J; Dicarlo M; Wolf T
Med Care; 2008 Sep; 46(9 Suppl 1):S123-31. PubMed ID: 18725824
[TBL] [Abstract][Full Text] [Related]
46. Evaluating the long-term effect of FOBT in colorectal cancer screening.
Luo D; Cambon AC; Wu D
Cancer Epidemiol; 2012 Feb; 36(1):e54-60. PubMed ID: 22075536
[TBL] [Abstract][Full Text] [Related]
47. Strategies for increasing participation in mail-out colorectal cancer screening programs: a systematic review and meta-analysis.
Goodwin BC; Ireland MJ; March S; Myers L; Crawford-Williams F; Chambers SK; Aitken JF; Dunn J
Syst Rev; 2019 Nov; 8(1):257. PubMed ID: 31685010
[TBL] [Abstract][Full Text] [Related]
48. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
[TBL] [Abstract][Full Text] [Related]
49. Reasons for never and intermittent completion of colorectal cancer screening after receiving multiple rounds of mailed fecal tests.
Green BB; BlueSpruce J; Tuzzio L; Vernon SW; Aubree Shay L; Catz SL
BMC Public Health; 2017 May; 17(1):531. PubMed ID: 28558663
[TBL] [Abstract][Full Text] [Related]
50. Self-rated health is prospectively associated with uptake of screening for the early detection of colorectal cancer, not vice versa.
Neter E; Stein N; Rennert G; Hagoel L
Eur J Cancer Prev; 2016 Jul; 25(4):282-7. PubMed ID: 26230609
[TBL] [Abstract][Full Text] [Related]
51. Effect of reminders mailed to general practitioners on colorectal cancer screening adherence: a cluster-randomized trial.
Le Breton J; Ferrat É; Attali C; Bercier S; Le Corvoisier P; Brixi Z; Veerabudun K; Renard V; Bastuji-Garin S
Eur J Cancer Prev; 2016 Sep; 25(5):380-7. PubMed ID: 26340058
[TBL] [Abstract][Full Text] [Related]
52. Adherence to continuous screening for colorectal neoplasia.
Myers RE; Balshem AM; Wolf TA; Ross EA; Millner L
Med Care; 1993 Jun; 31(6):508-19. PubMed ID: 8501998
[TBL] [Abstract][Full Text] [Related]
53. Additional mailing phase for FIT after a medical offer phase: The best way to improve compliance with colorectal cancer screening in France.
Piette C; Durand G; Bretagne JF; Faivre J
Dig Liver Dis; 2017 Mar; 49(3):308-311. PubMed ID: 27810401
[TBL] [Abstract][Full Text] [Related]
54. Longitudinal adherence to colorectal cancer screening guidelines.
Cyhaniuk A; Coombes ME
Am J Manag Care; 2016 Feb; 22(2):105-11. PubMed ID: 26885670
[TBL] [Abstract][Full Text] [Related]
55. Using a computer to teach patients about fecal occult blood screening. A randomized trial.
Miller DP; Kimberly JR; Case LD; Wofford JL
J Gen Intern Med; 2005 Nov; 20(11):984-8. PubMed ID: 16307621
[TBL] [Abstract][Full Text] [Related]
56. Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study.
Coronado GD; Green BB; West II; Schwartz MR; Coury JK; Vollmer WM; Shapiro JA; Petrik AF; Baldwin LM
Cancer; 2020 Feb; 126(3):540-548. PubMed ID: 31658375
[TBL] [Abstract][Full Text] [Related]
57. Behavioral interventions to increase adherence in colorectal cancer screening.
Myers RE; Ross EA; Wolf TA; Balshem A; Jepson C; Millner L
Med Care; 1991 Oct; 29(10):1039-50. PubMed ID: 1921523
[TBL] [Abstract][Full Text] [Related]
58. First-year implementation of mailed FIT colorectal cancer screening programs in two Medicaid/Medicare health insurance plans: qualitative learnings from health plan quality improvement staff and leaders.
Baldwin LM; Schneider JL; Schwartz M; Rivelli JS; Green BB; Petrik AF; Coronado GD
BMC Health Serv Res; 2020 Feb; 20(1):132. PubMed ID: 32085767
[TBL] [Abstract][Full Text] [Related]
59. Factors Influencing Implementation of a Colorectal Cancer Screening Improvement Program in Community Health Centers: an Applied Use of Configurational Comparative Methods.
Petrik AF; Green B; Schneider J; Miech EJ; Coury J; Retecki S; Coronado GD
J Gen Intern Med; 2020 Nov; 35(Suppl 2):815-822. PubMed ID: 33107003
[TBL] [Abstract][Full Text] [Related]
60. Patient preferences and adherence to colorectal cancer screening in an urban population.
Wolf RL; Basch CE; Brouse CH; Shmukler C; Shea S
Am J Public Health; 2006 May; 96(5):809-11. PubMed ID: 16571715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
